DICER1 and pleuropulmonary blastoma: The gold standard for definitive diagnosis is histopathological and immunohistochemical analysis, with molecular and genetic studies, such as DICER1 mutation screening in pleuropulmonary blastoma, increasingly used to refine diagnosis [4].